PEMF therapy for pemf therapy for migraine
PEMF UKMIGRAINE · NEUROVASCULAR HEADACHE

PEMF therapy for migraine

Migraine is one of the most disabling conditions the WHO tracks. PEMF therapy is studied for prevention frequency reduction and acute attack management — but cannot replace NICE-aligned migraine medicine.

Reviewed 2026-05-08

In 40 seconds

Migraine affects roughly 1 in 7 UK adults — about 10 million people — and is consistently ranked among the WHO's top causes of years-lived-with-disability. Standard care follows NICE CKS guidance: acute treatment with triptans + NSAIDs, prevention with propranolol, topiramate, candesartan, anti-CGRP injections (where indicated). PEMF therapy is a non-pharmacological adjunct — the evidence is modest but coherent for migraine-day reduction. It does not replace your migraine specialist or prescribed prophylaxis.

Quick facts

Migraine ≠ headache — what's actually happening

Migraine is a neurovascular event, not a simple headache. The current understanding involves cortical spreading depression, trigeminovascular activation, and CGRP (calcitonin gene-related peptide) release driving inflammation in the meningeal blood vessels. Symptoms — throbbing pain, photophobia, phonophobia, nausea, sometimes aura — reflect this cascade, not muscle tension or sinus pressure.

UK first-line care: lifestyle and trigger management, followed by acute treatment (triptans + NSAIDs), and preventive medication for those with ≥4 migraine days per month. The newest preventive class — anti-CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) — has transformed care for chronic migraineurs but remains tightly NICE-criteria gated.

PEMF and the neurostimulation devices (sTMS — Cefaly, Nerivio, gammaCore) are different. The neurostimulation devices target specific cranial nerves at high precision and are MHRA-registered medical devices for migraine. Whole-body PEMF in clinic is lower intensity, broader effect, and operates as a wellness adjunct rather than a medical device.

How PEMF may help migraine

Typical UK protocol

PhaseFrequencyDurationGoal
Trial2× per week4 weeksEstablish baseline migraine days, tolerance
Prevention2× per week8–12 weeksReduce monthly migraine-day count
Maintenance1× per weekOngoingSustain reduction

Use a Migraine Trust headache diary from day one. Without daily logging, you cannot tell whether monthly migraine days have reduced — and the only useful metric in migraine prevention is days per month, not pain intensity.

What the evidence shows

Practical advice before booking

Related guides on PEMF UK

Comorbidity

PEMF for anxiety

Anxiety co-occurs with migraine in roughly 50% of chronic cases.

Trigger

PEMF for insomnia and sleep

Disrupted sleep is the most reported migraine trigger.

Comorbidity

PEMF for fibromyalgia

Fibromyalgia and migraine frequently co-occur — PEMF may support both.

Contraindications

Hard exclusions — do not have PEMF if any apply:

Discuss with your GP or specialist before booking if any apply:

NOT contraindications — these are commonly misunderstood:

Specific to this condition: Epilepsy or seizure history requires explicit GP clearance. If you have aura with motor symptoms (hemiplegic migraine), confirm with your migraine specialist before starting PEMF.

Frequently asked questions

Will PEMF stop my migraines completely?

Probably not. The realistic outcome from migraine prevention work — pharmacological or PEMF — is reducing monthly migraine days, not eliminating them. Studies report 30–50% migraine-day reduction after 8–12 weeks of regular PEMF. That's meaningful but not cure.

Can I have PEMF during a migraine attack?

Most UK clinics will not run a session during an active attack — patients usually find lying still in a dark room more useful. PEMF is primarily a prevention tool, not an acute treatment.

How is PEMF different from Cefaly or Nerivio?

Cefaly, Nerivio and gammaCore are MHRA-registered medical devices for migraine that target specific cranial nerves at high precision. Whole-body PEMF is lower intensity, broader effect, and classed as a wellness adjunct rather than a medical device. The medical devices have stronger migraine-specific evidence; PEMF has broader systemic benefits.

Should I stop my preventive medication?

No. PEMF is additional, not alternative. Any change to prescribed prophylaxis should be a decision with your GP or migraine specialist over time, based on diary data — not driven by PEMF alone.

Will PEMF affect my anti-CGRP injections?

There are no documented interactions between PEMF and erenumab, fremanezumab, galcanezumab or other anti-CGRP medications. The mechanisms are independent.

What's the UK cost?

Typical UK private clinic pricing is £40–£90 per session. A 12-week prevention trial (24 sessions) typically costs £700–£1,500. Compare against the cost of unmanaged migraine days you currently lose.

Find a PEMF clinic near you

We list every credible PEMF therapy provider in the UK so you can find one near home.